Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Artes Biotechnology
Artes Biotechnology
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Schenck Process FPM becomes Coperion
Effective August 1, 2024, the company will officially transition its name under Coperion, whilst also providing more resources and broader technology capabilities to customers
Torbay Pharma strengthens leadership team to support North American growth strategy
The company has welcomed Mohammed Nazir as Chief Operating Officer (COO) and Tara Slivey as Chief Product Officer (CPO)
Ingenza expands codABLE gene design algorithm to aid recombinant protein production in yeast
The codABLE platform can help to accelerate the development and production of proteins in yeast hosts
DevPro Biopharma and Bespak complete early studies for novel sustainable albuterol inhaler
The novel formulation exhibits a low global warming potential (GWP) and shows comparable performance to Ventolin HFA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Manufacturing
ARTES and Basic Pharma near completion of their joint rHSA project
The collaborative project involved the production of recombinant human serum albumin (rHSA)
Media
Offering packet solutions for biopharmaceutical processes
Artes Biotechnology, and Minapharm Pharmaceuticals and Chemical Industries have made a business alliance to out-license their respective biopharmaceutical technologies
Research & Development
ARTES and BioSun announce codevelopment for HPV vaccine
ARTES Biotechnology and BioSun Pharmed are tojoin forces to develop and manufacture an HPV (human papilloma virus) vaccine in Iran
Research & Development
Artes Biotechnology and Burnet Institute join forces to develop novel hepatitis C vaccine
The project will combine Burnet's HepSeeVaxDelta3 technology with Artes’ Metavax technology
Research & Development
ARTES and Burnet join forces to develop anti-malaria vaccine
Transmission-blocking vaccines could play a significant role in the eventual eradication of malaria
Manufacturing
ARTES Biotechnology to collaborate with Bio Farma on vaccine development
First agreement for VLP-based vaccine technology transfer signed on 1 July in Bandung
Research & Development
Artes acquires Anavax VLP technology
Will develop processes for specific vaccines
Subscribe now